We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Comesto is a peer to peer web and app based service that enables professional food buyers to purchase directly from suppliers.  They are a membership funded trading platform.  The platform gives their members access to the whole market eliminating single brochures.  Comesto offers industry buyers a complete purchasing, invoicing and scheduling management service and for suppliers their aim is to provide a simple cost effective way to increase sales.  
days to go: Expired investment: £34,970
Crafty Nectar are a cider subscription service, sourcing ciders from independent producers and delivering to customers UK wide. They have £85k revenue to date and the aim to widen the availability of craft cider for all. They connect people with traditionally made ciders which are often not available in supermarkets. 
days to go: Expired investment: £145,810
NoshyCircle intends to disrupt the £8.5 billion UK takeaway market by offering healthy home-cooked meals with ingredients and their nutritional value clearly displayed on deliveries. Consumers can use the app to order their meals prepared by cooks in their neighbourhood. NoshyCircle ensures that the cooks are registered with their local council having a food hygiene rating of three or above. The company also strives to make sure that all its deliveries arrive in an eco-friendly packaging and delivery solution. NoshyCircle enables anyone passionate about cooking to register themselves as cooks and start their virtual kitchen. It currently has 20 such people on its platform. NoshyCircle will use the funds to scale its presence to the rest of London by the end of 2021 and expand its social media presence to attract more consumers to grow its business.

Pitch Rated

42%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £91,424
Fuudel seamlessly connects food operators to consumers using an on demand service. Their platform goes beyond ordering, providing cutting edge tools and services to help food businesses to thrive. Founder Dabier Miya previously had a highly successful enterprise software sales career and in 2004 began what was intended to be a one off investment in a restaurant venture which then led to a decade journey and half a dozen restaurants. 
days to go: Expired investment: £70,675
WELD is a fitness company on a mission to make on-demand health, fitness and wellbeing available to all ages & abilities. The company allows users and instructors to set the time and place for the training session, rent out their home or commercial spaces for activities, or interact 1-2-1 online. This approach, the company believes, helps personal trainers, hit by the Covid-19 lockdown, find clients. WELD also allows trainers to set their prices and keep 90% of their fees, and lets customers enjoy a 2% commission on referrals for every future session taken in perpetuity. WELD aims to tap into the $94 billion global fitness and wellness market that grew 8.7% from 2018/19. The company's primary target audience is Generation Z that, the company believes, embraced wellness. WELD will use the investment to improve its platform, boost marketing and plug the fitness & wellness gap. 

Pitch Rated

56%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £199,227
Creating Scottish cocktails that are high quality and ready-to-drink. The Venom Project's drinks consist of 5 flavours available in cans that contain 8% alcohol and are currently sold in off-licenses in Scotland, as well as over 300 retailers. In the first 7 months of trading, the company has been listed by over 250 stockists and sold more than 150k units. This has resulted in sales of £500k with the team growing from 3 to 10 members to handle demand. More than 250 stores have requested re-orders on a monthly basis and The Venom Project has predicted that 250k units per month will be reached in the near future. Funds will allow the company to escalate their manufacturing process to meet consumer demand, as well as acquire more stockists to attract new customers to the brand. A new manufacturing process will also allow the business to print their cans, which will aid in reducing production costs.
days to go: Expired investment: £62,170
H2O-ganics is using brand new technology to transform UK crop-growing. They are able to use this technology to grow vegetables indoors, without the need for pesticides and protected from disease and environmental factors.
days to go: Expired investment: £76,418
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph